Efficacy and safety of anti-interleukin-6 treatment in familial Mediterranean fever: a systematic literature review
Although the duration of follow-up of TCZ was short, we concluded that TCZ might present an acceptable profile regarding efficacy and safety in adult FMF patients. Our data suggest that TCZ could be a good treatment option after IL-1 inhibitors and warrants further investigation.
Authors
- O. Saidane (ORCID: https://orcid.org/0000-0002-7521-8018)
- L. Rouached (ORCID: https://orcid.org/0000-0002-4623-6284)
- L. Abdelmoula (ORCID: https://orcid.org/0000-0003-2000-4415)
- A. Ben Tekaya (ORCID: https://orcid.org/0000-0003-3385-2165)
- A. Jerbi (ORCID: https://orcid.org/0000-0002-1347-8332)
- R. Tekaya (ORCID: https://orcid.org/0000-0001-9294-9771)
- I. Mahmoud (ORCID: https://orcid.org/0000-0001-6596-7050)
- S. Bouden (ORCID: https://orcid.org/0000-0003-3820-0393)
Institutions
- University of Sfax (TN)
- Hôpital Charles-Nicolle (TN)
- Hopital Universitaire Habib Bourguiba (TN)
- Tunis El Manar University (TN)
Publication Details
- Journal
- Reumatologia/Rheumatology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.5114/reum/199741
- Citations
- 1
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81